Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management

Vasc Health Risk Manag. 2020 Jun 12:16:231-239. doi: 10.2147/VHRM.S223331. eCollection 2020.

Abstract

Erectile dysfunction (ED) is defined as a man's consistent or recurrent inability to attain and/or maintain penile erection enough for successful vaginal intercourse. ED affects a large part of the population, increasing its incidence with age and comorbidities. It is estimated by the year 2025, 322 million men will suffer from ED. Incidence of ED has been related not only to chronic diseases such as diabetes mellitus, metabolic syndrome, hyperlipidemia, psychiatric diseases or urinary tract diseases, but also to hypertension and especially to antihypertensive treatments. This review summarizes current knowledge about the management of ED in hypertensive men and its role as cardiovascular disease predictor.

Keywords: antihypertensive agents; cardiovascular diseases; erectile dysfunction; hypertension.

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects*
  • Clinical Decision-Making
  • Erectile Dysfunction / diagnosis
  • Erectile Dysfunction / epidemiology
  • Erectile Dysfunction / physiopathology
  • Erectile Dysfunction / therapy*
  • Humans
  • Hypertension / diagnosis
  • Hypertension / drug therapy*
  • Hypertension / epidemiology
  • Hypertension / physiopathology
  • Male
  • Penile Erection / drug effects*
  • Phosphodiesterase 5 Inhibitors / adverse effects
  • Phosphodiesterase 5 Inhibitors / therapeutic use*
  • Risk Factors
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Phosphodiesterase 5 Inhibitors